We did not find results for: edit my account.
Check spelling or type a new query.
Discovery-phase pharmaceutical company
Editas Medicine is a clinical-stage biotechnology company which is developing therapies based on CRISPR–Cas9 gene editing technology. Editas is based in Cambridge, Massachusetts and has facilities in Boulder, Colorado. en.wikipedia.org
Stock price: EDIT (NasdaqGS) $18.15 -0.64 (-3.41%)
Fri, Jan 21, 2022, 4:00PM EST
Maybe you would like to learn more about one of these?